Pro-atherothrombotic effects of leptin in human coronary endothelial cells

Summary

Adipocytes are nowadays recognised as cells able to produce and secrete a large variety of active substances termed adipokines, which exert direct effects on vascular cells. Among these adipokines, leptin has been proposed to play a role in the pathophysiology of acute coronary syndromes, as well as in increasing cardiovascular risk. At the moment, however, the mechanisms linking leptin to cardiovascular disease are not completely understood. This study investigates the effects of leptin, in a concentration range usually observed in the plasma of patients with increased cardiovascular risk or measurable in patients with acute coronary syndromes, on tissue factor (TF) and cellular adhesion molecules (CAMs) expression in human coronary endothelial cells (HCAECs). We demonstrate that leptin induces transcription of mRNA for TF and CAMs by real-time PCR. In addition, we show that this adipokine promotes surface expression of TF and CAMs that are functionally active since we observed increased procoagulant activity and leukocyte adhesion on cell surface. Leptin effects appear modulated by eNOS-production of oxygen free radicals through the activation of the transcription factor, nuclear factor(NF)-κB, since L-NAME, Superoxide Dismutase and NF-κB inhibitors suppressed CAMs and TF expression. Data of the present study, although in vitro, indicate that leptin may exert direct effects on human coronary endothelial cells by promoting CAMs and TF expression and support the hypothesis that this adipokines, besides being involved in the pathophysiology of obesity, might play a relevant role as an active mediator linking obesity to cardiovascular disease.

Keywords

Adhesion molecules - adipokines - atherothrombosis - leptin - obesity - tissue factor

• References

• 1 Hubert HB, Feinleib M, McNamara PM. et al. Obesity as an independent risk factor for cardiovascular disease: a 26– year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-977.
• 2 Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96: 939-994.
• 3 Sowers JR. Obesity as a cardiovascular risk factor. Am J Med 2003; 115: 37-41.
• 4 Considine RV, Sinha MK, Heiman ML. et al. Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans. N Engl J Med 1996; 334: 292-295.
• 5 Jequier E. Leptin signaling, adiposity, and energy balance. Ann NY Acad Sci 2002; 967: 379-388.
• 6 Bodary PF, Westrick RJ, Wickenheiser KJ. et al. Effect of leptin on arterial thrombosis following vascular injury in mice. J Am Med Assoc 2002; 287: 1706-1709.
• 7 Konstantinides S, Schäfer K, Koschnick S. et al. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 2001; 108: 1533-1540.
• 8 Bodary PF, Shen Y, Ohman M. et al. Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance. Arterioscler Thromb Vasc Biol 2007; 27: 70-76.
• 9 Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-126.
• 10 Price DT, Loscalzo J. Cellular adhesion molecules and atherogenesis. Am J Med 1999; 107: 85-97.
• 11 Simionescu M. Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler Thromb Vasc Biol 2007; 27: 266-274.
• 12 Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
• 13 O’Brien KD, MCDonald TO, Chait A. et al. Neovascular expression of E-selectin, intercellular adhesion molecule-1 and vascular adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996; 93: 672-682.
• 14 Toschi V, Gallo R, Lettino M. et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997; 95: 594-599.
• 15 Ragni M, Cirillo P, Pascucci I. et al. A monoclonal antibody against tissue factor shortens tissue-plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis. Circulation 1996; 93: 1913-1920.
• 16 Bierhaus A, Chen J, Liliensiek B. et al. LPS and cytokine activated endothelium. Semin Thromb Hemost 2000; 26: 571-587.
• 17 Golino P, Ragni M, Cirillo P. et al. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med 1996; 02: 35-40.
• 18 Cirillo P, De Rosa S, Pacileo M. et al. Human urotensin II induces Tissue Factor and cellular adhesion molecules expression in human coronary endothelial cells. J Thromb Haemost 2008; 06: 726-736.
• 19 Boloumie A, Marumo T, Lafontan M. et al. Leptin induces oxidative stress in human endothelial cells. FASEB J 1999; 13: 1231-1238.
• 20 Korda M, Kubant R, Patton S. et al. Leptin-induced endothelial dysfunction in obesity. Am J Physiol Heart Circ Physiol 2008; 295: H1514-1521.
• 21 Renard P, Ernest I, Houbion A. et al. Development of a sensitive multi-well colori-metric assay for active NF-kappaB. Nucleic Acids Res 2001; 29: E21.
• 22 Wilcox JN, Smith KM, Schwartz S. et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-2843.
• 23 Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary artery disease. AHA nutrition committee. Circulation 1998; 97: 2099-2100.
• 24 Jequier E. Leptin signaling, adiposity, and energy balance. Ann NY Acad Sci 2002; 967: 379-388.
• 25 Fruhbeck G. Intracellular signalling pathways activated by leptin. Biochem J 2006; 393: 7-20.
• 26 Singh P, Hoffmann M, Wolk R. et al. Leptin induces C-Reactive Protein expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2007; 27: e302-e307.
• 27 Soderberg S, Ahren B, Jansson JH. et al. Leptin is associated with increased risk of myocardial infarction. J Int Med 1999; 246: 409-418.
• 28 Soderberg S, Ahren B, Stegmayr B. et al. Leptin Is a Risk Marker for First-Ever Hemorrhagic Stroke in a Population-Based Cohort. Stroke 1999; 30: 328-337.
• 29 Taneli F, Yegane S, Ulman C. et al. Increased Serum Leptin Concentrations in Patients with Chronic Stable Angina Pectoris and ST-Elevated Myocardial Infarction. Angiology 2006; 57: 267-272.
• 30 Wallace AM, McMahon AD, Packard CJ. et al. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 2001; 104: 3052-3056.
• 31 Wolk R, Berger P, Lennon R. et al. Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol 2004; 44: 1819-1824.
• 32 Blankenberg S, Rupprecht HJ, Bickel C. et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001; 104: 1336-1342.
• 33 Ridkler PM, Hennekens CH, Roitman-Johnson B. et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998; 351: 88-92.
• 34 Flohe L, Brigelius-Flohe R, Saliou C. et al. Redox regulation of NF-kappa B activation. Free Radic Biol Med 1997; 22: 1115-1126.
• 35 Barnes PJ, Karin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory disease. N Engl J Med 1997; 336: 1066-1071.
• 36 Oeth P, Parry GC, Mackman N. Regulation of the tissue factor gene in human monocytic cells. Arteriocler Thromb Vasc Biol 1997; 17: 365-374.
• 37 Chien-Chun W, Wei-Ning L, Chiang-Wen L. et al. Involvement of p42/p44 MAPK, p38 MAPK, JNK, and NF-κB in IL-1β-induced VCAM-1 expression in human tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2005; 288: L227-L237.
• 38 Chen CC, Chen JJ, Chou CY. Protein kinase C- but not p44/42 mitogen-activated protein kinase, p38, or c-Jun NH₂-terminal kinase is required for intercellular adhesion molecule-1 expression mediated by interleukin-1β: involvement of sequential activation of tyrosine kinase, nuclear factor-κB-inducing kinase, and IκB kinase 2. Mol Pharmacol 2000; 58: 1479-1489.
• 39 Ritchie ME. Nuclear factor-κB is selectively and markedly activated in humans with unstable angina pectoris. Circulation 1998; 98: 1707-1713.
• 40 Wilson SH, Best PJ, Edwards WD. et al. Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable an-gina pectoris. Atherosclerosis 2002; 160: 147-153.
• 41 Kralisch S, Sommer G, Stangl V. et al. Secretory products from human adipocytes impair endothelial function via nuclear factor κB. Atherosclerosis 2008; 196: 523-531.
• 42 Skilton M, Nakhla S, Sieveking DP. et al. Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells. Clin Exp Pharmacol Physiol 2005; 32: 839-844.
• 43 Napoleone E, Di Santo E, Amore C. et al. Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possibile link between obesità and cardiovascular risk?. J Thromb Haemost 2007; 05: 1462-1468.
• 44 Rafail S, Kits K, Schaefer K. et al. Leptin induces the expression of functional tissue factor in human neuthrophils and peripheral blood mononuclear cells through JAK2-dependent mechanisms and TNFα involvement. Thromb Res 2008; 122: 366-375.
• 45 Dubey L, Zeng H, Hashmi S. et al. Association of plasma leptin levels and complexity of the culprit lesion in patients with unstable angina. Int J Cardiol 2008; 126: 183-189.
• 46 Amasyali B, Aytemir K, Kose S. et al. Admission plasma leptin level strongly correlates with the success of thrombolytic therapy in patients with acute myocardial infarction. Angiology 2006; -2007 57: 671-680.